Brazen Funding: How Much Did They Raise & Key Investors

How Much Did Brazen Raise?
Funding & Key Investors

Brazen, a company focused on expertly engineered supplements to alleviate menstrual discomfort, has secured $35K in total financing. The company recently announced a substantial expansion capital round, bringing in $35K to fuel its growth. This latest investment underscores Brazen's strategic position in the wellness market, particularly within the burgeoning women's health sector.

What is Brazen?

Brazen

Manufacturing

Health & Nutrition Products

Retail

Brazen specializes in developing research-backed, all-natural supplements designed to address menstrual cycle challenges. Their product line includes PMS Support, formulated to fortify against stress and balance pre-period hormones, and Cramp Support, engineered to reduce tension and ease pain. All products are manufactured in the USA, emphasizing quality and efficacy in their approach to women's health solutions.

How much funding has Brazen raised?

Brazen has raised a total of $35K across 1 funding round:

2021

Debt

$35K

Debt (2021): $35K with participation from PPP

Key Investors in Brazen

PPP

Public-Private Partnership

What's next for Brazen?

With significant Series B/C stage funding, Brazen is poised for substantial expansion. The recent influx of capital is expected to drive advancements in product development, enhance marketing initiatives, and potentially broaden distribution channels. This strategic investment will likely enable Brazen to further solidify its market presence and cater to a growing demand for natural, effective menstrual health solutions.

See full Brazen company page

See More Financial Insights